Showing results (1-10 of 64) with videos related to
Sort By:
Pageof 7
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|November 20, 2009
Interactions with GluR1 AMPA receptors could influence the therapeutic usefulness of minocycline in ALSHari Manev, Radmila ManevJournal of Biomedical Discovery and Collaboration|May 26, 2006
Nomen est Omen: do antidepressants increase p11 or S100A10?Hari Manev, Radmila ManevCardiovascular Psychiatry and Neurology|July 31, 2010
Benefits of neuropsychiatric phenomics: example of the 5-lipoxygenase-leptin-Alzheimer connectionHari Manev, Radmila ManevCritical Reviews in Neurobiology|December 8, 2004
5-Lipoxygenase as a putative link between cardiovascular and psychiatric disordersRadmila Manev, Hari ManevMedical Hypotheses|November 10, 2005
5-Lipoxygenase (ALOX5) and FLAP (ALOX5AP) gene polymorphisms as factors in vascular pathology and Alzheimer's diseaseHari Manev, Radmila ManevMedical Hypotheses|June 27, 2006
Could treatment with arundic acid (ONO-2506) increase vulnerability for depression?Radmila Manev, Hari ManevMedical Hypotheses|November 10, 2004
The meaning of mammalian adult neurogenesis and the function of newly added neurons: the "small-world" networkRadmila Manev, Hari ManevJournal of Affective Disorders|June 5, 2003
Glia as a putative target for antidepressant treatmentsHari Manev, Tolga Uz, Radmila ManevMedical Hypotheses|April 24, 2007
Possible role for interactions between 5-lipoxygenase (5-LOX) and AMPA GluR1 receptors in depression and in antidepressant therapyRadmila Manev, Danijela Mrazovac, Hari ManevProgress in Neuro-Psychopharmacology & Biological Psychiatry|August 10, 2010
Cyclooxygenases and 5-lipoxygenase in Alzheimer's diseaseHari Manev, Hu Chen, Svetlana Dzitoyeva, et al.Pageof 7